Entera Bio Stock Market Value
| ENTX Stock | USD 2.34 0.11 4.93% |
| Symbol | Entera |
Entera Bio Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entera Bio. If investors know Entera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entera Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.26) | Revenue Per Share | Quarterly Revenue Growth (0.92) | Return On Assets | Return On Equity |
The market value of Entera Bio is measured differently than its book value, which is the value of Entera that is recorded on the company's balance sheet. Investors also form their own opinion of Entera Bio's value that differs from its market value or its book value, called intrinsic value, which is Entera Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entera Bio's market value can be influenced by many factors that don't directly affect Entera Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entera Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Entera Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entera Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Entera Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Entera Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Entera Bio.
| 12/21/2024 |
| 01/20/2025 |
If you would invest 0.00 in Entera Bio on December 21, 2024 and sell it all today you would earn a total of 0.00 from holding Entera Bio or generate 0.0% return on investment in Entera Bio over 30 days. Entera Bio is related to or competes with NLS Pharmaceutics, Alterity Therapeutics, and Immutep. Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally ... More
Entera Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Entera Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Entera Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.9 | |||
| Information Ratio | 0.1067 | |||
| Maximum Drawdown | 27.1 | |||
| Value At Risk | (4.76) | |||
| Potential Upside | 9.38 |
Entera Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Entera Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Entera Bio's standard deviation. In reality, there are many statistical measures that can use Entera Bio historical prices to predict the future Entera Bio's volatility.| Risk Adjusted Performance | 0.1028 | |||
| Jensen Alpha | 0.5096 | |||
| Total Risk Alpha | 0.3941 | |||
| Sortino Ratio | 0.1658 | |||
| Treynor Ratio | (1.06) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Entera Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Entera Bio Backtested Returns
Entera Bio appears to be unstable, given 3 months investment horizon. Entera Bio secures Sharpe Ratio (or Efficiency) of 0.1, which denotes the company had a 0.1 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Entera Bio, which you can use to evaluate the volatility of the firm. Please utilize Entera Bio's Mean Deviation of 3.2, coefficient of variation of 882.85, and Downside Deviation of 2.9 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Entera Bio holds a performance score of 8. The firm shows a Beta (market volatility) of -0.47, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Entera Bio are expected to decrease at a much lower rate. During the bear market, Entera Bio is likely to outperform the market. Please check Entera Bio's potential upside, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether Entera Bio's price patterns will revert.
Auto-correlation | -0.65 |
Very good reverse predictability
Entera Bio has very good reverse predictability. Overlapping area represents the amount of predictability between Entera Bio time series from 21st of December 2024 to 5th of January 2025 and 5th of January 2025 to 20th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Entera Bio price movement. The serial correlation of -0.65 indicates that roughly 65.0% of current Entera Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.65 | |
| Spearman Rank Test | -0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Entera Bio lagged returns against current returns
Autocorrelation, which is Entera Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Entera Bio's stock expected returns. We can calculate the autocorrelation of Entera Bio returns to help us make a trade decision. For example, suppose you find that Entera Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Entera Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Entera Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Entera Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Entera Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Entera Bio Lagged Returns
When evaluating Entera Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Entera Bio stock have on its future price. Entera Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Entera Bio autocorrelation shows the relationship between Entera Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Entera Bio.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Entera Stock Analysis
When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.